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Conclusions: LMS PCI can be safely performed using radial arterial access. Operator
confidence to use radial access increases with period of time and experience.
Multivessel Disease
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Partial Revascularization Plus Medical Treatment Versus Medical Treatment Alone
In Patients With Multivessel Coronary Artery Disease Not Eligible For CABG
Mohamed A Sadaka, Mohamed loutfi, Mohamed Sobhy
Alexandria University, Alexandria, Egypt
Aim: The purpose of this study was to compare the impact of incomplete revascularization
(IR) plus OMT to OMT alone on 1 year clinical outcomes (death, hospitalization for
decompensated heart failure, acute coronary syndrome (ACS), angina class, ejection
fraction (EF) and repeated revascularization) in patients with multivessel coronary artery
disease (MVD) who were not eligible for coronary bypass graft surgery (CABG).
Methods: This is a prospective randomized study conducted on 50 selected patients with
chronic stable angina and without past history of revascularization; they have documented
MVD by standard coronary angiography and CABG were the only option of revascu-
larization but were refused by surgeon. All patients had non-viable myocardium
documented by viability studies were excluded from the study.
Patients were randomized 1:1 into two groups, group (I): 25 patients were subjected to
OMT alone and group (II): 25 patients were subjected to IR {PCI in one or two vessel
only with drug eluting stents (DES)} plus OMT. All patients were subjected to 1 year
follow up.
Results: The baseline patients’ characteristics were matched in the two studied groups.
Also, high syntax score (33) was almost found in majority of patients in both groups (23
patients in OMT group and in 24 patients in IR plus OMT group; p  1.000). All
patients were followed up for 1 year ; death occurred slightly more in IR plus OMT group
(16% versus 12%; p1.000), hospitalization for decompensated CHF occurred more in
the OMT group (28% versus 12%; p0.289), ACS occurred more in the OMT group
(32% versus 16%; p0.321) while freedom from angina occurred more in IR plus OMT
group (20% versus 4%; p0.189); however all these differences were not statistically
significant. In IR plus OMT group; TVR occurred in 16% of patients while non-TVR in
32% of patients. The OMT alone did not affect neither the level of angina class nor EF;
while the IR plus OMT markedly improved the decline in the level of angina class (p 
0.011), but it did not improve EF significantly (p 0.326).
Conclusion: In patients with MVD who were not eligible for CABG; IR plus OMT
was not superior to OMT alone in improving the 1year clinical outcomes except the
improvement in the level of angina class, which could be the adopted strategy to improve
the quality of life in such patients.
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Impact Of Multivessel Disease In Patients With Chronic Total Occlusion On
Six-month Angiographic And Two-year Clinical Outcomes
Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Sung Il Im,
Sun Won Kim, Jin Oh Na, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim,
Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh
Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea, Republic of
Background: Chronic total occlusion (CTO) intervention is still challenging because of
the limited procedural success rate and higher recurrence. It is not clear whether the
presence of multivessel disease (MVD) will negatively impact on angiographic and clinical
outcomes following CTO intervention as compared with single vessel disease (SVD).
Methods: A total of 238 consecutive patients (pts) underwent CTO intervention were
divided into two groups according to the number of treated vessel (MVD with CTO:
n149 pts, SVD with CTO: n89 pts). Six-month angiographic and twelve-month
clinical outcomes were compared between the two groups.
Results: The baseline clinical characteristics were balanced between the two groups
except higher incidence of myocardial infarction (MI, 31.5 vs. 17.9 p0.021) and a lower
left ventricular ejection fraction (LVEF, 47.9712.1% vs. 52.759.3%, p0.001) in the
MVD group. The overall procedural success rate, procedural characteristics and procedure
related complications including perforation and dissection were not different between the
two groups. Angiographic outcomes at 6 months and major clinical outcomes up to 24
months were similar between the two groups except a trend toward higher incidence of
total death and major adverse cardiac events (MACE) in the MVD group (Table).
Conclusions: Once the CTO intervention was successful, the presence of MVD in
CTO patients did not negatively impact on 2-year major clinical outcomes.
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Is It Safe to Perform Staged Percutaneous Coronary Intervention On Non-Culprit
Vessels During the Index Hospitalization in Patients with ST-Segment Elevation
Myocardial Infarction and Multivessel Coronary Artery Disease?
Joshua P Loh, Hironori Kitabata, Lakshmana K Pendyala, Israel M Barbash,
Danny Dvir, Sa’ar Minha, Salem M Badr, Rebecca Torguson, Lowell F Satler,
Kenneth M Kent, William O Suddath, Augusto D Pichard, Ron Waksman
MedStar Washington Hospital Center, Washington, DC
Background: In patients with ST-segment elevation myocardial infarction (STEMI)
and multivessel disease undergoing primary percutaneous coronary intervention (PCI),
staged non-culprit vessel PCI at a separate session is recommended. It is not known
whether performing staged PCI within the same hospitalization as the primary PCI is safe.
Methods: We analyzed 282 consecutive STEMI patients with multivessel disease who
underwent primary PCI followed by staged PCI of the non-culprit vessel. Patients were
categorized into staged PCI in the same hospitalization (n184) and staged PCI at a
separate hospitalization within 8 weeks of primary PCI (n98). In-hospital outcomes and
procedural complications after staged PCI were analyzed.
Results: Baseline characteristics, STEMI presentation and procedure characteristics
were similar in both groups. Contrast amount used was higher in the separate versus same
hospitalization group for both index (175 vs. 153ml, p0.011) and staged (144 vs. 120ml,
p0.004) PCI. More left main PCI occurred in the separate hospitalization group during
the staged PCI (3.9 vs. 0.3%, p0.008). Angiographic success of staged PCI was similar
in same versus separate hospitalization, with similar rates of vascular complications and
major bleeding, but a trend toward higher incidence of acute renal failure. Following
staged PCI, in-hospital major adverse cardiac events (3.3 vs. 1.0%, p0.43) and mortality
(2.7 vs. 0%, p0.17) were similar in both groups.
Conclusion: It is safe to perform staged PCI within the same hospitalization as primary
PCI, achieving similar procedural success and in-hospital outcomes as staged PCI at a
separate hospitalization. Higher contrast volume used during primary PCI and the
presence of left main lesion in non-culprit vessels may influence the decision to stage the
PCI at a separate hospitalization.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 2 , S u p p l S , 2 0 1 3
S18
C
O
R
O
N
A
R
Y
In-hospital outcomes following staged percutaneous coronary intervention
Staged PCI in
the same
hospitalization
(n184)
Staged PCI at
a separate
hospitalization
(n98) P value
Major adverse cardiac events 6 (3.3%) 1 (1.0%) 0.43
Death 5 (2.7%) 0 (0%) 0.17
Urgent coronary artery
bypass graft
1 (0.5%) 1 (1.0%) 1.00
Procedure-related acute renal
failure
7 (3.8%) 1 (1.0%) 0.27
Vascular complications 6 (3.3%) 3 (3.1%) 1.00
Major bleeding 3 (1.6%) 2 (2.0%) 1.00
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Role Of Coronary Artery Calcium Score In Patients With Stable Angina Pectoris
Underwent Multivessel Percutaneous Coronary Intervention
Jiangli Han,1 Fangfang Wang,1 Rong He,1 Xiangzhu Zeng,2 Fuchun Zhang,1
Lijun Guo,1 Wei Gao1
1Department of Cardiology & Key Laboratory of Cardiovascular Molecular Biology and
Regulatory peptides, Ministry of Health; Peking University Third Hospital, Beijing, China
2Department of Radiology, Peking University Third Hospital, Beijing, China
Objectives: This study sought to identify whether coronary artery calcium score (CCS)
is associated with procedure complexity, procedure-related complications and long-term
clinical outcomes in patients with stable angina pectoris (SAP) underwent multivessel
percutaneous coronary intervention (PCI).
Methods: 145 SAP patients (male/female, 103/42; age, 6510 years) who underwent
first multivessel PCI following multi-detector computed tomography (MDCT) were
enrolled. We standardized MDCT results into 3 CCS categories (0 to 100, 101 to 400,
and 400) according to recent guidelines. Complex PCI was defined as use of high
pressure balloon, kissing balloon and/or rotablator. Procedure-related complications
included target artery occlusion, dissection, perforation, no/slow flow and emergency
coronary artery bypass grafting. Main adverse cardiac events (MACE) were defined as a
combined end point of death, non-fatal myocardial infarction, target lesion revascular-
ization and rehospitalization for cardiac ischemic events.
Results: As compared with the patients with CCS 100 (n39), those patients with
CCS 101 to 400 (n41) and CCS400 (n65) had significantly higher PCI procedure
complexity (20.5% vs 46.3% vs 38.5, p  0.040). And patients with CCS400 (n65)
had a higher rate of procedure-related complications than patients with CCS184400
(n80) (26.2% vs 6.3%, p 0.001). Three patients (0.02%) were missed during a median
of 21 months’ (1 	 69 months) follow-up. Kaplan-Meier survival analysis showed that
patients with CCS 0 to 100, 101 to 400 and 400 had similar cumulative non-events
survival rates (89.5% vs 82.4% vs 75.0%, p  0.342). However, it showed significant
different cumulative non-events survival rates in female subgroup (100% vs 83.3% vs
58.8%, Log rank 6.005, p  0.049).
Conclusions: Preprocedural CCS assessment by MDCT indicates complexity of PCI
and procedure-related complications in patients with SAP underwent multivessel PCI.
CCS is more relevant with MACE in female patients.
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Hybrid Coronary Revascularization (hcr) In Patients With Multi-vessel Coronary
Disease (mvd): Mid-term Results
Alberto Repossini,1Maurizio Tespili,2 Antonio Saino,2 Igor Kotelnikov,1
Annalisa Moggi,1 Lorenzo Di Bacco,1 Claudio Muneretto1
1Cardiac Surgery, University of Brescia, Brescia, Italy 2Cardiology Unit, Azienda
Ospedaliera Bolognini, Seriate, Italy
Objective: Hybrid Coronary Revascularization, meaning Left Mammary Artery on Left
Anterior Descending (MIDCAB) combined with non-LAD PCI stenting, is considered
as a viable alternative to conventional CABG through sternotomy or to multi-vessel PCI,
in order to perform a functionally complete revascularization. We report our results and
mid-term outcomes of this therapeutic strategy.
Methods: Since January 2009 up to October 2012, 70 consecutive patients underwent
hybrid revascularization after Heart Team evaluation. Coronary risk was assessed by
SYNTAX score, and patients were partitioned in tertiles according to the score categories
(22 low risk, 22 and 33 intermediate risk, 33 high risk). Pre-operative risk
assessment was upgraded to EuroSCORE II for all patients. Long-term outcomes, major
adverse cardiac and cerebrovascular events (MACCE) rate and repeated target vessels
revascularization (TVR) rate were evaluated by Kaplan-Meier curve and log-rank test.
Results: Mean age was 66.3  12.0 years and 83.8% of patients were males. Mean
SYNTAX score was 28,22  7 (mean SYNTAX score in patients with Left main
involved 33,5 4,5). Mean EuroSCORE II was 4,05 1,83. PCI was performed in all
patients (n70), in 52 pts (75,2%) before MIDCAB and in 24,8% of cases after surgery
(interval 2,2  1,3 months). In 12 patients (18,6%) Left Main was involved and
MIDCAB was performed prior to PCI. No intra-operative or in-hospital deaths were
reported. At follow-up one cardiac death for acute inferior myocardial infarction occurred.
Two patients with Left Main needed a repeated non-LAD revascularization: one case for
an acute myocardial infarction and the other due to recurrent angina with in-stent
restenosis at angiography. At 25  13 months follow-up the overall population freedom
from MACCEs rate was 82,6% (CI: 79,5% to 85,7%) and the freedom from TVRs rate
was 86,1% (CI: 82,9% to 89,3%). Despite the rate of MACCE and TVR was higher in
patients with intermediate and high coronary risk than in patients with SYNTAX score 
22, however such difference was not statistically significant (p  0,05).
Conclusions: Hybrid Coronary Revascularization is a viable option to perform a
minimally invasive functionally complete revascularization in high risk patient that can’t
undergo conventional revascularization. However this strategy has better results when
performed on patients with a SYNTAX score 22. In our experience patients with Left
Main HCR had a good outcome at the end of revascularization, although being burdened
by an high TVR rate.
Other
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Hybrid Coronary Revascularization Combining Off-pump Left Internal Mammary
Grafting And Percutaneous Coronary Intervention
Leif Thuesen, Ivy I Modrau, Per Hostrup Nielsen, Bøtker E Hans,
Evald H Christiansen, Lars R Krusell, Anne K Kaltoft, Michael Maeng,
Christian J Terkelsen, Steen D Kristensen, Jens F Lassen
Aarhus University Hospital, Aarhus N, Denmark
Aims: To assess procedural feasibility and early safety of hybrid coronary revasculariza-
tion, combining off-pump left internal mammary artery grafting to the left descendent
coronary artery (LAD) through an inferior J-hemisternotomy (JOPCAB) and percuta-
neous coronary intervention (PCI) of non-LAD lesions.
Methods and Results: A total of 100 consecutive patients with multivessel coronary
artery disease involving LAD were included in this prospective registry. JOPCAB was
performed prior to PCI in 89 (89%) patients, and PCI was scheduled prior to surgery in
11 (11%) patients with total occlusion of a non-LAD artery. Two of these patients were
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